The role of genetic polymorphisms regulating vitamin D levels in rheumatoid arthritis outcome: A Mendelian randomisation approach

Annals of the Rheumatic Diseases

Volumn 73, Issue 7, 2014, Pages 1430-1433

  Viatte, Sebastien ^a   Yarwood, Annie ^a   McAllister, Kate ^a   Al Mudhaffer, Shibeb ^a   Fu, Bo ^a,b   Flynn, Edward ^a   Symmons, Deborah P M ^a,c   Young, Adam ^d,e   Barton, Anne ^a,c  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^d St Albans City Hospital   (United Kingdom)

^e UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

VITAMIN D;

CYP24A1 GENE; CYP2R1 GENE; DHCR7 GENE; DISEASE SEVERITY; GC GENE; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOME ANALYSIS; HUMAN; LETTER; MENDELIAN RANDOMIZATION ANALYSIS; NADSYN1 GENE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; VITAMIN D METABOLISM;

ARTHRITIS; GENE POLYMORPHISM; OUTCOMES RESEARCH; RHEUMATOID ARTHRITIS;

ADULT; AGED; AMIDE SYNTHASES; ARTHRITIS, RHEUMATOID; CHOLESTANETRIOL 26-MONOOXYGENASE; FEMALE; HUMANS; MALE; MENDELIAN RANDOMIZATION ANALYSIS; MIDDLE AGED; OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS; POLYMORPHISM, SINGLE NUCLEOTIDE; SEVERITY OF ILLNESS INDEX; STEROID HYDROXYLASES; VITAMIN D; VITAMIN D-BINDING PROTEIN;

EID: 84902255578     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2013-204972     Document Type: Letter

References (11)

1. Boonstra A, Barrat FJ, Crain C, et al. 1alpha, 25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol 2001;167:4974-80. (Pubitemid 33009728)
2. Griffin MD, Lutz W, Phan VA, et al. Dendritic cell modulation by 1alpha, 25 dihydroxyvitamin D3 and its analogs: A vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc Natl Acad Sci USA 2001;98:6800-5. (Pubitemid 32538297)
3. Yarwood A, Martin P, Bowes J, et al. Enrichment of vitamin D response elements in RA-associated loci supports a role for vitamin D in the pathogenesis of RA. Genes Immun 2013;14:325-29.
4. Kerr GS, Sabahi I, Richards JS, et al. Prevalence of vitamin D insufficiency/deficiency in rheumatoid arthritis and associations with disease severity and activity. J Rheumatol 2011;38:53-9.
5. Rossini M, Maddali BS, La MG, et al. Vitamin D deficiency in rheumatoid arthritis: prevalence, determinants and associations with disease activity and disability. Arthritis Res Ther 2010;12:R216.
6. Mouterde G, Lukas C, Logeart I, et al. Predictors of radiographic progression in the ESPOIR cohort: The season of first symptoms may influence the short-term outcome in early arthritis. Ann Rheum Dis 2011;70:1251-56.
7. Wang TJ, Zhang F, Richards JB, et al. Common genetic determinants of vitamin D insufficiency: A genome-wide association study. Lancet 2010;376:180-8.
8. Ahn J, Yu K, Stolzenberg-Solomon R, et al. Genome-wide association study of circulating vitamin D levels. Hum Mol Genet 2010;19:2739-45.
9. Hingorani A, Humphries S. Nature's randomised trials. Lancet 2005;366:1906-8. (Pubitemid 41713974)
10. Cooper JD, Smyth DJ, Walker NM, et al. Inherited variation in vitamin D genes is associated with predisposition to autoimmune disease type 1 diabetes. Diabetes 2011;60:1624-31.
11. Viatte S, Plant D, Lunt M, et al. Investigation of rheumatoid arthritis genetic susceptibility markers in the early rheumatoid arthritis study further replicates the TRAF1 association with radiological damage. J Rheumatol 2013;40:144-56.